https://www.selleckchem.com/pr....oducts/dl-ap5-2-apv.
Real-world data on the effectiveness of boosters against COVID-19, especially as new variants continue to emerge, is limited. Our objective was to assess demographic, clinical, and outcome variables of patients requiring hospitalization for severe SARS-CoV-2 infection comparing fully vaccinated and boosted (FV, fully vaccinated (FV), and unvaccinated (UV) patients. This multicenter observational cohort analysis compared demographic, clinical, and outcome variables in FVB, FV, and UV adults hospitalized for COVID-19. Par
Aimer
Commentaire
Partagez
